Hudson Bay Capital Management »

Alpine Immune Sciences shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.8M 197k 19.06

More positions owned by Hudson Bay Capital Management

Amazon Call Option (AMZN)
Microsoft Corporation Put Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Meta Platforms Cl A Put Option (META)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Alphabet Cap Stk Cl C Put Option (GOOG)
Apple Put Option (AAPL)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
NVIDIA Corporation Put Option (NVDA)
salesforce Put Option (CRM)
Select Sector Spdr Tr Financial (XLF)
Adobe Systems Incorporated Put Option (ADBE)
Boeing Company Put Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Alpine Immune Sciences

Decheng Capital
RA Capital Management
Lynx1 Capital Management
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
Frazier Life Sciences Management
Cormorant Asset Management
OrbiMed Advisors
Vanguard Group
T. Rowe Price Associates
Commodore Capital
Octagon Capital Advisors
Franklin Resources
Citadel Advisors
Henderson Group

View all funds holding Alpine Immune Sciences